| 翻訳と辞書 |
| Bruesewitz v. Wyeth ： ウィキペディア英語版 |
Bruesewitz v. Wyeth
''Bruesewitz v. Wyeth'', , deals with whether a section of the National Childhood Vaccine Injury Act of 1986 preempts ''all'' vaccine design defect claims against vaccine manufacturers. The case has at its focus the issue of federal preemption.
==Background==
Hannah Bruesewitz, the daughter of the main petitioners in the case, received Wyeth's Tri-Immunol DTP vaccine as part of childhood immunizations. The Bruesewitzes claimed that Hannah's seizures and later developmental problems came from the vaccine. They filed suit in the "Vaccine Court", a special court within the United States Court of Federal Claims. Their petition was dismissed for failure to prove a link between the vaccine and Hannah's health problems. They proceeded to sue in Pennsylvania state court. The case was removed to the local federal court which proceeded to hold the claim preempted by a section of the National Childhood Vaccine Injury Act of 1986. The Third Circuit Court of Appeals affirmed.〔''Bruesewitz v. Wyeth'', (), Third Circuit affirms, (2008).〕 A petition for a writ of certiorari was granted on March 8, 2010, bringing the case to the Supreme Court.
In briefings before the Court, both sides argued over the specific language of the statutory provision.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Bruesewitz v. Wyeth」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|